Back to search

University of Leeds

Revealing Putative Drug Targets for Basal-Like Breast Cancer

Abstract

dc:description.abstract

The development of targeted drugs has revolutionised the treatment strategy for breast cancer, improving patients’ clinical outcome and quality of life. However, the lack of targetable proteins has limited treatment options for patients with Basal-like breast cancer to non-selective cytotoxic and cytostatic drugs. This research aimed to reveal putative drug targets for Basal-like breast cancer. The advances of sequencing technologies and computational methods have benefited drug target identification research, which is a critical early step in the drug discovery process. The method developed in this research integrated omic data and modelling approaches to uncover the transcriptional characteristics underlying Basal-like breast cancer. This molecular characterisation revealed potential candidates for further pharmaceutical intervention. To reveal putative drug targets for Basal-like breast cancer, an unsupervised clustering approach was first performed to study the heterogeneity in breast cancer. The clustering analysis revealed several differently expressed transcriptional factors in Basal-like breast cancer. Using a network modelling approach, these transcriptional factors were then prioritised according to their topological features. Assuming gene expression is the first proxy of protein expression, the expression correlations between critical candidate genes were explored at the protein level. Using bioinformatics platforms and databases, several putative protein-protein interactions that are associate with candidate genes were identified. This was followed by a specific target protein selection. Furthermore, a molecular docking analysis was performed to determine the structural characteristics and molecular recognition features of these interactions. Finally, a laboratory experiment was developed to evaluate the protein interactions in breast cancer cell lines. This research has not only identified putative drug targets for Basal-like, but also developed an integrative target identification approach that can be adapted easily to study other diseases.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hsu, Nien-yun
Advisor dc:contributor.advisor
  • Smith, James
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.834046

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Hsu, Nien-yun. Revealing Putative Drug Targets for Basal-Like Breast Cancer. doctoral thesis, University of Leeds, 2021.